Stock data

沛爾生醫*-創 (6949)

沛爾生醫*-創 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$1.93M, up 2.3% from a year earlier. EPS over the last four quarters totals -NT$7.14.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 沛爾生醫*-創 in Insightr